Estée Lauder Responds to COVID-19

The Estée Lauder Companies Inc. is undertaking several initiatives in response to COVID-19 to support its employees, consumers, stockholders and communities.
 
“As a company, we are continuing to find meaningful ways to lend our support as the world fights this health crisis. We are also taking actions to optimize our cost structure, in light of ongoing temporary store closures in many regions, and to enhance our liquidity during this unprecedented time,” said Fabrizio Freda, president and chief executive officer. “I am confident that the actions we are taking will enable us to effectively navigate through this challenging environment with agility and position us well for the recovery, much as we are starting to see in our Asia/Pacific region as stores reopen.”
 
Global Donations
 
The Estée Lauder Companies stands with the global community to help limit the spread of the virus and ease the related economic hardships faced by those it affects. The company, its brands and its foundations have made numerous donations and commitments, including:
 

• A $2 million grant to Doctors Without Borders/Médecins Sans Frontières (MSF) to support their continued life-saving response to coronavirus in under-resourced and highly impacted countries.
• A grant to support the establishment of The NYC COVID-19 Response & Impact Fund, administered by the New York Community Trust. The new $75 million fund, jointly formed through contributions from multiple philanthropic partners, will provide support for New York City’s social services and cultural community organizations.
• In China, over $800,000 was awarded to relief efforts. Funds will support the Red Cross Society of China, Shanghai Charity Foundation and Give2Asia. Additionally, $1.4 million worth of in-kind donations were provided to the China Women's Development Foundation to support front line medical staff.
• The Estée Lauder brand is donating two million surgical masks for front-line workers in New York.
• Clinique is donating 50,000 skin care products as a thank you to the doctors and nurses in New York City's hospitals.
• M∙A∙C Cosmetics' Viva Glam Fund will be allocating $10 million to 250 local organizations all over the world that are providing essential needs and services to people at higher risk during the COVID-19 pandemic.

 
The Estée Lauder Companies is also contributing to the broader COVID-19 relief efforts by producing hand sanitizer in its United States, United Kingdom and Belgium manufacturing facilities for high-need groups and populations, including front-line medical staff.
 
Retail and Manufacturing Operations
 
As a result of COVID-19 Directives, most retail stores in The Americas and Europe, the Middle East & Africa, whether operated by the company or its customers, have been closed since mid-March, and air travel continues to be largely curtailed, primarily impacting the company’s travel retail business. However, in recent weeks, many retail stores have been reopening in Asia/Pacific, and sales growth of the company’s products online has accelerated globally.
 
The company will continue to assess, in accordance with the guidance of governments and healthcare authorities, when its stores in The Americas and Europe, the Middle East & Africa can reopen. Furthermore, it stands ready to support its retailers when they reopen their stores. At this time, a majority of the company’s facilities continue to manufacture and distribute products globally, albeit in a reduced capacity in light of the challenging environment.
 
Financial Measures
 
As the company prioritizes areas of growth and cash generation among its geographic regions, product categories, brands, and channels of distribution, it has taken the following actions:
 

• Announced salary reductions effective May 1, 2020 through October 31, 2020 for the executive chairman, CEO, executive leadership team, and other management.
• Announced that its Board of Directors will forgo their cash retainers through November 2020.
• Announced salary reductions for Leonard A. Lauder, chairman emeritus, and Ronald S. Lauder, chairman Clinique Laboratories LLC, of nearly 100% effective May 1, 2020 through October 31, 2020.
• Announced that regional decisions are being made for point-of-sale and field employees in locations where retail operations are closed or experiencing slow recovery, which will include unpaid temporary leaves of absence that allow employees to maintain healthcare benefits and access to COVID-19 support where permissible.
• Expanded cost control measures, including optimizing advertising and promotion spending, delaying certain capital investments, restricting business travel and ceasing non-essential hires and certain professional services.
• Issued $700 million aggregate principal amount of 2.6% Senior Unsecured Notes due 2030.
• Borrowed the full amount under its $1.5 billion revolving credit facility.
• Temporarily suspended share repurchases of its Class A Common Stock.
• Suspended the next quarterly cash dividend on its Class A and Class B Common Stock, which would have been paid in June 2020.

 
The company will continue to monitor the impact of COVID-19 and may adjust its action plans accordingly as the situation progresses. The company expects to provide an update when it reports fiscal 2020 third quarter earnings on May 1, 2020.
 
More Coronavirus News
 
Here’s a look at what some companies are doing to reduce the spread of coronavirus and how the epidemic will impact business in Q1 and beyond.